1073Tip A Phase I/IIa First In-Human Phase I Study of BI 1910, a Monoclonal Antibody Agonistic to TNFR2, As a Single Agent and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

T.C. Hernandez Guerrero,B. Doger de Spéville,J. Yachnin,K.S. Rohrberg, M. Borggren, P. Holmkvist, I. Karlsson, M. Meller, L. Mårtensson, J-A. Nilsson,M. Vaapil,M. Chisamore, J.E. Wallin, I. Teige,B. Frendeus, A. McAllister

Annals of Oncology（2024）

Cited 0|Views11

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined